The global cardiopulmonary bypass system market is projected to reach USD 270.9 million by 2033, growing from USD 197.3 million in 2023, reflecting a compound annual growth rate (CAGR) of 3.2% during ...

The world’s most advanced early detection test for testicular cancer – now the most common form of cancer among young men – is being launched in the UK. The non-invasive test has 97% sensitivity in a ...

QIAGEN today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation. These ...

Duchenne Muscular Dystrophy: diagnosis, clinical development and global researchMuscular dystrophy refers to a group of rare, genetic, progressive diseases that primarily affect the body’s muscles, ...

JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, announced the preliminary results of a ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphony IL-6 Test, the company’s lead product candidate, for presentation at the Society of Academic ...

Revenue and Sales Performance: For the fiscal third quarter of 2025, Biomerica reported net sales of $1.10 million, a 10% increase from $1.00 million recorded in the same quarter of the previous year.

WITH an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- ...